PDF icon Download PDF
Semin Thromb Hemost 2011; 37(5): 431-439
DOI: 10.1055/s-0031-1281035
EDITORIAL

© Thieme Medical Publishers

2011 Eberhard F. Mammen Award Announcements

Emmanuel J. Favaloro1
  • 1Department of Haematology, ICPMR, Westmead Hospital, Westmead, NSW Australia
Further Information

Publication History

Publication Date:
18 November 2011 (online)

   Permissions and Reprints
Preview

As we have mentioned on several occasions,[1] [2] [3] Thieme, the publisher of Seminars in Thrombosis and Hemostasis, recently created the Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards in honor of Eberhard F. Mammen (Fig. [1]), and in recognition of his contribution to this field and to the journal that he both founded and steered for over three decades. These awards began in 2009, under two categories:

Figure 1 Dr. Eberhard F Mammen (1930–2008).

Most popular article awards: Awarded to the authors of the most popular articles published in Seminars in Thrombosis and Hemostasis. The awards are determined by the editor in chief on the basis of user statistics from Thieme eJournals from the preceding 2 years. The awards comprise two major cash prizes of US $1000 plus “open access” status for these articles thereafter. Young investigator awards: Best presentation or meeting abstract by a young investigator, as presented or delivered to an international meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. Up to six cash prizes of US $1000 in any year. Awardees are expected to prepare a review or other article related to the topic of their presentation for publication in Seminars in Thrombosis and Hemostasis.

Further details of the awards and the award winners are posted online (http://www.thieme.com/sth), and previous award winner announcements are also available in print.[4] [5] [6]

It is therefore with great pleasure that we would like to announce the latest winners of the Eberhard F. Mammen award for the most popular articles from Seminars in Thrombosis and Hemostasis for the period 2009 to 2010 inclusive, as well as the young investigator awards related to meetings held in 2010.

REFERENCES

  • 1 Favaloro E J. Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasis—the closing issue for 2008.  Semin Thromb Hemost. 2008;  34 693-696
    Search in Google Scholar
  • 2 Favaloro E J. A tribute to Eberhard F. Mammen, M.D. (1930–2008).  Semin Thromb Hemost. 2008;  34 (8) 703-707
    Search in Google Scholar
  • 3 Favaloro E J. Editorial. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009.  Semin Thromb Hemost. 2009;  35 1-2
    Search in Google Scholar
  • 4 Favaloro E J. Editorial. Winners of the Inaugural Eberhard F. Mammen Award for Most Popular Article.  Semin Thromb Hemost. 2009;  35 587-590
    Search in Google Scholar
  • 5 Favaloro E J. Editorial. 2009 Eberhard F. Mammen Young Investigator Award Winners.  Semin Thromb Hemost. 2010;  36 469-470
    Search in Google Scholar
  • 6 Favaloro E J. Winners of the 2010 Eberhard F. Mammen award for most popular article during 2008–2009.  Semin Thromb Hemost. 2010;  36 (7) 685-692
    Search in Google Scholar
  • 7 Sobieraj-Teague M, O'Donnell M, Eikelboom J. New anticoagulants for atrial fibrillation.  Semin Thromb Hemost. 2009;  35 (5) 515-524
    Search in Google Scholar
  • 8 Favaloro E J, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly.  Semin Thromb Hemost. 2009;  35 (7) 695-710
    Search in Google Scholar
  • 9 Mariani G, Bernardi F. Factor VII deficiency.  Semin Thromb Hemost. 2009;  35 (4) 400-406
    Search in Google Scholar
  • 10 Jurk K, Kehrel B E. Platelets: physiology and biochemistry.  Semin Thromb Hemost. 2005;  31 (4) 381-392
    Search in Google Scholar
  • 11 Viiala N O, Larsen S R, Rasko J E. Gene therapy for hemophilia: clinical trials and technical tribulations.  Semin Thromb Hemost. 2009;  35 (1) 81-92
    Search in Google Scholar
  • 12 Asherson R A, Cervera R, Merrill J T, Erkan D. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.  Semin Thromb Hemost. 2008;  34 (3) 256-266
    Search in Google Scholar
  • 13 Tripodi A, van den Besselaar A. Laboratory monitoring of anticoagulation: where do we stand?.  Semin Thromb Hemost. 2009;  35 (1) 34-41
    Search in Google Scholar
  • 14 Zhou Z, Nguyen T C, Guchhait P, Dong J F. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.  Semin Thromb Hemost. 2010;  36 (1) 71-81
    Search in Google Scholar
  • 15 Lippi G, Franchini M, Favaloro E J, Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the “French paradox.”  Semin Thromb Hemost. 2010;  36 (1) 59-70
    Search in Google Scholar
  • 16 Lippi G, Favaloro E J, Franchini M, Guidi G C. Milestones and perspectives in coagulation and hemostasis.  Semin Thromb Hemost. 2009;  35 (1) 9-22
    Search in Google Scholar
  • 17 Tincani A, Bazzani C, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment.  Semin Thromb Hemost. 2008;  34 (3) 267-273
    Search in Google Scholar
  • 18 Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency.  Semin Thromb Hemost. 2009;  35 (4) 426-438
    Search in Google Scholar
  • 19 Harenberg J, Wehling M. Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.  Semin Thromb Hemost. 2008;  34 (1) 39-57
    Search in Google Scholar
  • 20 Althaus K, Greinacher A. MYH9-related platelet disorders.  Semin Thromb Hemost. 2009;  35 (2) 189-203
    Search in Google Scholar
  • 21 Fareed J, Hoppensteadt D A, Fareed D et al.. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.  Semin Thromb Hemost. 2008;  34 (1) 58-73
    Search in Google Scholar
  • 22 Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases.  Semin Thromb Hemost. 2008;  34 (8) 772-778
    Search in Google Scholar
  • 23 Pierangeli S S, Chen P P, Raschi E et al.. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.  Semin Thromb Hemost. 2008;  34 (3) 236-250
    Search in Google Scholar
  • 24 McGlasson D L, Fritsma G A. Whole blood platelet aggregometry and platelet function testing.  Semin Thromb Hemost. 2009;  35 (2) 168-180
    Search in Google Scholar
  • 25 de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders.  Semin Thromb Hemost. 2009;  35 (4) 356-366
    Search in Google Scholar
  • 26 Favaloro E J. Clinical utility of the PFA-100.  Semin Thromb Hemost. 2008;  34 (8) 709-733
    Search in Google Scholar
  • 27 Wong R C, Favaloro E J. Clinical features, diagnosis, and management of the antiphospholipid syndrome.  Semin Thromb Hemost. 2008;  34 (3) 295-304
    Search in Google Scholar
  • 28 Brenner B, Kuperman A A, Watzka M, Oldenburg J. Vitamin K–dependent coagulation factors deficiency.  Semin Thromb Hemost. 2009;  35 (4) 439-446
    Search in Google Scholar
  • 29 Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.  Semin Thromb Hemost. 2009;  35 (3) 313-324
    Search in Google Scholar
  • 30 Asselta R, Peyvandi F. Factor V deficiency.  Semin Thromb Hemost. 2009;  35 (4) 382-389
    Search in Google Scholar
  • 31 Blum W, Porcu P. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.  Semin Thromb Hemost. 2007;  33 (4) 350-354
    Search in Google Scholar
  • 32 Blann A, Shantsila E, Shantsila A. Microparticles and arterial disease.  Semin Thromb Hemost. 2009;  35 (5) 488-496
    Search in Google Scholar
  • 33 Hunt B J. Pediatric antiphospholipid antibodies and antiphospholipid syndrome.  Semin Thromb Hemost. 2008;  34 (3) 274-281
    Search in Google Scholar
  • 34 Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing.  Semin Thromb Hemost. 2009;  35 (2) 150-157
    Search in Google Scholar
  • 35 Galli M. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.  Semin Thromb Hemost. 2008;  34 (4) 329-334
    Search in Google Scholar
  • 36 Menegatti M, Peyvandi F. Factor X deficiency.  Semin Thromb Hemost. 2009;  35 (4) 407-415
    Search in Google Scholar
  • 37 Enjeti A K, Lincz L F, Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology.  Semin Thromb Hemost. 2007;  33 (8) 771-779
    Search in Google Scholar
  • 38 Harenberg J. New anticoagulants in atrial fibrillation.  Semin Thromb Hemost. 2009;  35 (6) 574-585
    Search in Google Scholar
  • 39 Duga S, Salomon O. Factor XI deficiency.  Semin Thromb Hemost. 2009;  35 (4) 416-425 y
    Search in Google Scholar
  • 40 Harenberg J. Development of new anticoagulants: present and future.  Semin Thromb Hemost. 2008;  34 (8) 779-793
    Search in Google Scholar
  • 41 Hellgren M. Hemostasis during normal pregnancy and puerperium.  Semin Thromb Hemost. 2003;  29 (2) 125-130
    Search in Google Scholar
  • 42 Levi M, Löwenberg E C. Thrombocytopenia in critically ill patients.  Semin Thromb Hemost. 2008;  34 (5) 417-424
    Search in Google Scholar
  • 43 Meltzer M E, Doggen C J, de Groot P G, Rosendaal F R, Lisman T. The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.  Semin Thromb Hemost. 2009;  35 (5) 468-477
    Search in Google Scholar
  • 44 Peyvandi F, Palla R, Menegatti M, Mannucci P M. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management.  Semin Thromb Hemost. 2009;  35 (4) 349-355
    Search in Google Scholar
  • 45 Zuern C S, Lindemann S, Gawaz M. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management.  Semin Thromb Hemost. 2009;  35 (3) 295-306
    Search in Google Scholar
  • 46 Berntorp E, Salvagno G L. Standardization and clinical utility of thrombin-generation assays.  Semin Thromb Hemost. 2008;  34 (7) 670-682
    Search in Google Scholar
  • 47 Baskurt O K, Meiselman H J. Blood rheology and hemodynamics.  Semin Thromb Hemost. 2003;  29 (5) 435-450
    Search in Google Scholar
  • 48 Roberts H R, Hoffman M, Monroe D M. A cell-based model of thrombin generation.  Semin Thromb Hemost. 2006;  32 (Suppl 1) 32-38
    Search in Google Scholar
  • 49 Bernardi E, Pesavento R, Prandoni P. Upper extremity deep venous thrombosis.  Semin Thromb Hemost. 2006;  32 (7) 729-736
    Search in Google Scholar
  • 50 Prisco D, Grifoni E. The role of D-dimer testing in patients with suspected venous thromboembolism.  Semin Thromb Hemost. 2009;  35 (1) 50-59
    Search in Google Scholar
  • 51 Prechel M, Walenga J M. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.  Semin Thromb Hemost. 2008;  34 (1) 86-96
    Search in Google Scholar
  • 52 Kamphuisen P W, Rosendaal F R, Büller H R. Hemostatic abnormalities and arterial thrombosis.  Semin Thromb Hemost. 2009;  35 (5) 449-450
    Search in Google Scholar
  • 53 Levi M, Schouten M, van der Poll T. Sepsis, coagulation, and antithrombin: old lessons and new insights.  Semin Thromb Hemost. 2008;  34 (8) 742-746
    Search in Google Scholar
  • 54 Coppola A, Tufano A, Cerbone A M, Di Minno G. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism.  Semin Thromb Hemost. 2009;  35 (7) 683-694
    Search in Google Scholar
  • 55 Selleng K, Selleng S, Greinacher A. Heparin-induced thrombocytopenia in intensive care patients.  Semin Thromb Hemost. 2008;  34 (5) 425-438
    Search in Google Scholar
  • 56 Mezzano D, Quiroga T, Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays.  Semin Thromb Hemost. 2009;  35 (2) 242-254
    Search in Google Scholar
  • 57 Hayward C P, Favaloro E J. Diagnostic evaluation of platelet disorders: the past, the present, and the future.  Semin Thromb Hemost. 2009;  35 (2) 127-130
    Search in Google Scholar
  • 58 Peyvandi F, Favaloro E J. Rare bleeding disorders.  Semin Thromb Hemost. 2009;  35 (4) 345-347
    Search in Google Scholar
  • 59 Wong R C, Favaloro E J. Antiphospholipid antibodies and the antiphospholipid syndrome. I: pathogenesis, clinical features, diagnosis, and management. Preface.  Semin Thromb Hemost. 2008;  34 (3) 213-218
    Search in Google Scholar
  • 60 Lippi G, Favaloro E J, Franchini M. Laboratory diagnostics and therapy in thrombosis and hemostasis: from bedside to bench to bedside.  Semin Thromb Hemost. 2009;  35 (1) 3-8
    Search in Google Scholar
  • 61 Franchini M, Lippi G, Favaloro E J. Coagulopathies and thrombosis: usual and unusual causes and associations, part I.  Semin Thromb Hemost. 2009;  35 (3) 257-259
    Search in Google Scholar
  • 62 Kamphuisen P W, Rosendaal F R, Büller H R. Hemostatic abnormalities and arterial thrombosis.  Semin Thromb Hemost. 2009;  35 (5) 449-450
    Search in Google Scholar
  • 63 Levi M. Hemostasis and thrombosis in critically ill patients.  Semin Thromb Hemost. 2008;  34 (5) 415-416
    Search in Google Scholar
  • 64 Favaloro E J. Hot topics II: an editorial collection of current issues and controversies in thrombosis and hemostasis.  Semin Thromb Hemost. 2008;  34 (1) 3-6
    Search in Google Scholar
  • 65 Favaloro E J. A tribute to Eberhard F. Mammen, M.D. (1930–2008).  Semin Thromb Hemost. 2008;  34 (8) 703-707
    Search in Google Scholar

Emmanuel J FavaloroPh.D. F.F.Sc. (RCPA) 

Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital

SWAHS, Westmead, NSW, 2145, Australia

Email: emmanuel.favaloro@swahs.health.nsw.gov.au